ОПЫТ ПРИМЕНЕНИЯ мКРЛ У БОЛЬНЫХ С ЛЕКАРСТВЕННОЙ УСТОЙЧИВОЙ ТУБЕРКУЛЕЗА И ОЦЕНКА ЭФФЕКТИВНОСТИ, ТЩАТЕЛЬНОГО МОНИТОРИНГА И НЕЖЕЛАТЕЛЬНЫХ ЯВЛЕНИЙ [PDF]
Buletinul Academiei de Ştiinţe a Moldovei: Ştiinţe MedicaleЦель. Изучить частоту побочных нежелательных явлений при применении новых препаратов в схеме лечении больных с МЛУ ТБ и оценить эффективность новых укороченных схем лечения. Материал и методы исследования.
Ирада АХУНДОВА +4 more
doaj +5 more sources
Cardiovascular complications of immune checkpoint inhibitors [PDF]
Качественная клиническая практика, 2020 Cardiovascular toxicity of cancer therapies remains an urgent problem today. The creation of highly effect antitumor drugs also means the appearance of new adverse effects.
A. A. Kulievа +6 more
doaj +2 more sources
Cardiotoxic Effects of Yew Tree and Pink Periwinkle Alkaloids [PDF]
, 2021 Antitumour herbal medicines based on pink periwinkle and yew tree alkaloids are included in combination therapies for many types of cancer. The use of these classes of products may entail cardiotoxic effects leading to life-threatening conditions.
A. A. Ivanova +3 more
core +2 more sources
Современные аспекты ранней диагностики кардиотоксических осложнений лекарственной терапии в онкологии (обзор литературы) [PDF]
, 2022 Анализу подвергнуты данные литературы, представленные в открытых достоверных медицинских источниках, о современных методах наиболее ранней диагностики кардиотоксических осложнений, в особенности в период их субклинических проявлений.
Гелия Рифкатовна Гиматдинова +4 more
core +2 more sources
Potential of primary drug prevention of cardiotoxicity in the context of anticancer therapy [PDF]
, 2023 Aim. To search early signs of cardiotoxicity in patients receiving anticancer therapy and evaluate the effectiveness of cardioprotection with an angiotensin-converting enzyme inhibitor, beta-blocker and myocardial cytoprotector.Material and methods.
A. G. Nosova +7 more
core +2 more sources
Atrial Fibrillation in Cancer Patients: Who is at Risk? [PDF]
, 2022 Cancer is the second leading cause of mortality in the world, second only to cardiovascular diseases. Simultaneously cancer mortality has been steadily decreasing due to the development of new chemotherapy and targeted drugs and the improvement of ...
D. A. Vyzhigin +4 more
core +2 more sources
Характеристика морфофункциональных параметров сердца и биомаркеров повреждения миокарда у пациентов различных возрастных групп на фоне терапии антрациклиновыми антибиотиками [PDF]
, 2021 Оценка изменений внутрисердечной гемодинамики, а также уровней тропонина I и NT-proBNP при достижении средних кумулятивных доз антрациклинов (250 мг/м2 по доксорубицину) у пациентов различных возрастных ...
Ватутин, Н. Т. +1 more
core +1 more source
Cardioprotective Strategies for Doxorubicin-induced Cardiotoxicity: Present and Future [PDF]
, 2022 The improvement of drugs and protocols of chemotherapeutic treatment has led to improved outcomes and survival in patients with cancer. But along with this, at first glance a positive point, there was another interdisciplinary problem, which is the need ...
A. M. Chaulin, D. V. Duplyakov
core +2 more sources
Clinical Manifestations of Cardiotoxicity in Acute Leukemia and Methods for their Examination [PDF]
, 2023 Currently, more and more attention is paid to cardiotoxicity, which develops against the background of anticancer treatment. Achievements of modern oncology are associated with the use of effective combinations of chemotherapeutic drugs and radiation ...
Abdukhalimovna, Amerova Dilafruz +2 more
core +2 more sources
MODERN APPROACHES TO DETECTING EARLY SUBCLINICAL CARDIOTOXICITY INDUCED BY CHEMOTHERAPY IN PATIENTS WITH BREAST CANCER [PDF]
, 2018 In recent decades, developed countries of the world have made progress in the treatment of breast cancer, both because of the early detection of cancer and the use of modern methods of treatment (target therapy and chemotherapy, radiation therapy and ...
A. A. Avalyan +3 more
core +2 more sources